Skip to content

A study to assess the feasibility of implementation of enhanced recovery after surgery in childhood cancer conducted at Tata Memorial Hospital

ERAS pathway in Pediatric surgical oncology-feasibility and outcome - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055034
Enrollment
100
Registered
2023-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C15-C26- Malignant neoplasms of digestive organs Health Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx Health Condition 3: C30-C39- Malignant neoplasms of respiratory and intrathoracic organs Health Condition 4: C73-C75- Malignant neoplasms of thyroid and other endocrine glands Health Condition 5: O- Medical and Surgical

Interventions

Intervention1: Enhanced recovery after surgery (ERAS) pathway measures in childhood cancer surgeries: The 19 components of ERAS pathway are considered for the study
7 being pre-operative, 5 intra-operative and 7 post-operative components. To be recorded till 30 days after surgery. Control Intervention1: Pre-existing data on Enhanced recovery after surgery: Data w

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children undergoing surgery for solid tumours

Exclusion criteria

Exclusion criteria: Day care surgery

Design outcomes

Primary

MeasureTime frame
To assess the morbidity and the hospital length of stay for surgery considered from the day of surgery till the day of dischargeTimepoint: The assessments will be done : Before, during & after surgery. Morbidity assessment will be done by CLAVIEN-DINDO CLASSIFICATION

Secondary

MeasureTime frame
(i) To study the feasibility & compliance of ERAS pathway in pediatric surgical oncology practice (ii) To study the patient/parent satisfaction of Pediatric ERAS (iii) To study the effect of pediatric ERAS on 30-day hospital readmission ratesTimepoint: Before, during & after surgery. And 30 days post surgery

Countries

India

Contacts

Public ContactDr Sajid Qureshi

Tata Memorial Hospital

sajidshafiques@hotmail.com02224174281

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026